Australia markets closed

Skye Bioscience, Inc. (SKYE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.02+0.03 (+0.23%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,588
5,819
6,012
2,931
1,944
Selling general and administrative
5,902
7,852
6,095
4,916
4,345
Total operating expenses
11,490
13,672
12,106
7,848
6,289
Operating income or loss
-11,490
-13,672
-12,106
-7,848
-6,289
Interest expense
812.638
906.27
665.133
769.159
706.385
Total other income/expenses net
207.59
-23,163
-6,602
96.788
436.27
Income before tax
-12,097
-37,641
-19,475
-8,520
-6,559
Income tax expense
5.641
3.6
6.741
2.1
1.6
Income from continuing operations
-12,103
-37,645
-19,482
-8,522
-6,561
Net income
-12,103
-37,645
-19,482
-8,522
-6,561
Net income available to common shareholders
-12,103
-37,645
-19,482
-8,522
-6,561
Basic EPS
-11.55
-
-8.77
-5.00
-7.50
Diluted EPS
-11.55
-
-8.77
-5.00
-7.50
Basic average shares
4,639
-
2,221
1,626
922.987
Diluted average shares
4,639
-
2,221
1,626
925.683